MedPath

Human Repeat Insult Patch Test to Evaluate Personal Lubricants

Not Applicable
Completed
Conditions
Edema
Erythema
Interventions
Device: "Chameleon" Personal Lubricant
Registration Number
NCT02737631
Lead Sponsor
Church & Dwight Company, Inc.
Brief Summary

The purpose of this test is to evaluate the sensitizing potential of a personal lubricant, as a result of repeated occlusive patch. The intervention will be applied for a total of 9 induction applications, followed by an approximately 2 week rest period, then followed by a 24-72 hour Challenge applications.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
222
Inclusion Criteria
  • good health as determined from screener
  • signed and dated informed consent
  • signed and dated HIPAA Form
Exclusion Criteria
  • subjects on test at any other research laboratory or clinic
  • known allergy or sensitivity to cosmetics and toiletries, including sunscreens, adhesives and/or topical drugs
  • pre-existing dermatologic conditions which have been diagnosed by a medical professional (e.g. psoriasis, eczema, etc.) which would interfere with this study
  • pre-existing other medical conditions (e.g. adult asthma, diabetes).
  • treatment with antibiotics, antihistamines or corticosteroids within two weeks prior to initiation of the test
  • chronic medication which could affect the results of the study (e.g., insulin, corticosteroids, antihistimines, steroidal or non-steroidal anti-inflammatory drugs [except for therapeutic maintenance dosage of aspirin], antibiotics, steroid inhalers, etc.)
  • known pregnant or nursing women

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Healthy subject"Chameleon" Personal LubricantHealthy subjects exposed to "Chameleon" personal lubricant via occlusive patch
Primary Outcome Measures
NameTimeMethod
Number of Patients That Showed Sensitization Reaction to the Test Material at Challenge24, 48 and 72 hours after patch application
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Harrison Research Laboratories, Inc.

🇺🇸

Union, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath